Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.

Steinmetz NF, Ablack AL, Hickey JL, Ablack J, Manocha B, Mymryk JS, Luyt LG, Lewis JD.

Small. 2011 Jun 20;7(12):1664-72. doi: 10.1002/smll.201000435. Epub 2011 Apr 26.

2.

Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.

Steinmetz NF, Cho CF, Ablack A, Lewis JD, Manchester M.

Nanomedicine (Lond). 2011 Feb;6(2):351-64. doi: 10.2217/nnm.10.136.

3.

Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles.

Leong HS, Steinmetz NF, Ablack A, Destito G, Zijlstra A, Stuhlmann H, Manchester M, Lewis JD.

Nat Protoc. 2010 Aug;5(8):1406-17. doi: 10.1038/nprot.2010.103. Epub 2010 Jul 8.

4.

Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system.

Delehanty JB, Bradburne CE, Boeneman K, Susumu K, Farrell D, Mei BC, Blanco-Canosa JB, Dawson G, Dawson PE, Mattoussi H, Medintz IL.

Integr Biol (Camb). 2010 Jun;2(5-6):265-77. doi: 10.1039/c0ib00002g. Epub 2010 Jun 8.

PMID:
20535418
5.

Bisaryl hydrazones as exchangeable biocompatible linkers.

Dirksen A, Yegneswaran S, Dawson PE.

Angew Chem Int Ed Engl. 2010 Mar 8;49(11):2023-7. doi: 10.1002/anie.200906756. No abstract available.

6.

Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting.

Brunel FM, Lewis JD, Destito G, Steinmetz NF, Manchester M, Stuhlmann H, Dawson PE.

Nano Lett. 2010 Mar 10;10(3):1093-7. doi: 10.1021/nl1002526.

7.

Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.

Gonzalez MJ, Plummer EM, Rae CS, Manchester M.

PLoS One. 2009 Nov 23;4(11):e7981. doi: 10.1371/journal.pone.0007981.

8.

Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation.

Hong V, Presolski SI, Ma C, Finn MG.

Angew Chem Int Ed Engl. 2009;48(52):9879-83. doi: 10.1002/anie.200905087. No abstract available.

9.

Buckyballs meet viral nanoparticles: candidates for biomedicine.

Steinmetz NF, Hong V, Spoerke ED, Lu P, Breitenkamp K, Finn MG, Manchester M.

J Am Chem Soc. 2009 Dec 2;131(47):17093-5. doi: 10.1021/ja902293w.

10.

Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin.

Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M.

PLoS Pathog. 2009 May;5(5):e1000417. doi: 10.1371/journal.ppat.1000417. Epub 2009 May 1.

11.

Endocytosis via caveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation?

Kiss AL, Botos E.

J Cell Mol Med. 2009 Jul;13(7):1228-37. doi: 10.1111/j.1582-4934.2009.00754.x. Epub 2009 Mar 27. Review.

12.

Uptake and intracellular fate of surface-modified gold nanoparticles.

Nativo P, Prior IA, Brust M.

ACS Nano. 2008 Aug;2(8):1639-44. doi: 10.1021/nn800330a.

PMID:
19206367
13.

Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.

Wei B, Wei Y, Zhang K, Wang J, Xu R, Zhan S, Lin G, Wang W, Liu M, Wang L, Zhang R, Li J.

Biomed Pharmacother. 2009 May;63(4):313-8. doi: 10.1016/j.biopha.2008.07.086. Epub 2008 Sep 7.

PMID:
18823738
14.

The effect of particle design on cellular internalization pathways.

Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM.

Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8. doi: 10.1073/pnas.0801763105. Epub 2008 Aug 12.

15.

Multifunctional nanoparticles--properties and prospects for their use in human medicine.

Sanvicens N, Marco MP.

Trends Biotechnol. 2008 Aug;26(8):425-33. doi: 10.1016/j.tibtech.2008.04.005. Review.

PMID:
18514941
16.

Genome-free viral capsids as carriers for positron emission tomography radiolabels.

Hooker JM, O'Neil JP, Romanini DW, Taylor SE, Francis MB.

Mol Imaging Biol. 2008 Jul-Aug;10(4):182-91. doi: 10.1007/s11307-008-0136-5. Epub 2008 Apr 25.

PMID:
18437498
17.

Infusion of dye molecules into Red clover necrotic mosaic virus.

Loo L, Guenther RH, Lommel SA, Franzen S.

Chem Commun (Camb). 2008 Jan 7;(1):88-90.

PMID:
18401897
18.

Nanomedicine: application of nanobiotechnology in medical practice.

Jain KK.

Med Princ Pract. 2008;17(2):89-101. doi: 10.1159/000112961. Epub 2008 Feb 19. Review.

PMID:
18287791
19.

Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.

Khalil IA, Kogure K, Futaki S, Harashima H.

Int J Pharm. 2008 Apr 16;354(1-2):39-48. doi: 10.1016/j.ijpharm.2007.12.003. Epub 2007 Dec 14. Review.

PMID:
18242018
20.

Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo.

Kaiser CR, Flenniken ML, Gillitzer E, Harmsen AL, Harmsen AG, Jutila MA, Douglas T, Young MJ.

Int J Nanomedicine. 2007;2(4):715-33.

Items per page

Supplemental Content

Write to the Help Desk